Compound Evidence File
#EC-2026-0460
MENT (Trestolone Acetate)
Filed under Injectable Oils. The bureau holds 135 laboratory returns for this compound from 52 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
52 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 3 Jun 2026 | 11 Jul 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 10.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 12 Dec 2025 | 5 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 10.0 | 10.0 | 1 Mar 2026 | 13 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 25 Mar 2026 | 21 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Feb 2026 | 24 Apr 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 7 Apr 2026 | 6 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 6 Nov 2025 | 17 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Apr 2026 | 15 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Jan 2026 | 23 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 21 Jun 2026 | 3 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 6 Mar 2026 | 10 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Apr 2026 | 5 Aug 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 20 Dec 2025 | 10 Jun 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Nov 2025 | 11 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 24 Jan 2026 | 12 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 9.9 | 22 Jun 2026 | 4 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 9.9 | 9.9 | 9.9 | 6 Mar 2026 | 17 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Jun 2026 | 3 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Feb 2026 | 21 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 17 Jan 2026 | 8 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 28 Apr 2026 | 18 May 2026 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 9.2 | 9.2 | 9.2 | 24 Apr 2025 | 24 Apr 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.8 | 7.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.7 | 6.7 | 10.0 | 24 May 2026 | 24 May 2026 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 8.7 | 8.7 | 8.7 | 21 May 2025 | 21 May 2025 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 8.7 | 8.7 | 8.7 | 3 Jul 2025 | 3 Jul 2025 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 8.7 | 8.7 | 8.7 | 3 Jun 2025 | 3 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.5 | 7.4 | 9.7 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.3 | 7.0 | 9.6 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.2 | 8.2 | 8.3 | 21 May 2026 | 21 May 2026 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 8.0 | 8.0 | 8.0 | 28 Mar 2025 | 28 Mar 2025 |
| PeptiSlimCASE #VI-2026-0557 | X | 2 | 7.9 | 7.7 | 8.1 | 14 Jan 2025 | 24 May 2026 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 7.7 | 7.7 | 7.7 | 3 Jul 2025 | 3 Jul 2025 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 2 | 7.5 | 6.6 | 8.4 | 24 Apr 2025 | 25 May 2026 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 7.4 | 7.4 | 7.4 | 14 Jan 2025 | 14 Jan 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 7.3 | 7.0 | 7.6 | 20 Jun 2025 | 23 May 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 2 | 6.8 | 6.3 | 7.2 | 28 Mar 2025 | 24 May 2026 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 | 2 Jul 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 6.2 | 6.2 | 6.2 | 6 May 2025 | 6 May 2025 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 6.1 | 6.1 | 6.1 | 3 Jun 2025 | 3 Jun 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 6.1 | 6.1 | 6.1 | 3 Jul 2025 | 3 Jul 2025 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 5.9 | 5.9 | 5.9 | 28 Mar 2025 | 28 Mar 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 2 | 5.8 | 5.4 | 6.2 | 13 Feb 2025 | 21 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 5.6 | 5.6 | 5.6 | 3 Jul 2025 | 3 Jul 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 3 | 5.3 | 4.6 | 6.6 | 21 May 2025 | 17 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 | 14 Jan 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 5.0 | 5.0 | 5.0 | 24 Apr 2025 | 24 Apr 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 4.3 | 4.3 | 4.3 | 2 Apr 2025 | 2 Apr 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 3.7 | 3.7 | 3.7 | 2 Jul 2025 | 2 Jul 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 2.5 | 2.5 | 2.5 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for MENT (Trestolone Acetate) alone.